血脂论坛-3
Lipid Forum-3
11/22 10:00-12:00
大宴会厅C（3楼） (Grand Banquet Hall C (3rd Floor))
-
-
-
11:25-11:55专家访谈：血脂治疗展望Discussions and Prospects in Lipid Management
-
10:05-10:25ESC 2025热点聚焦：中国原研PCSK9i 助力血脂管理新方案ESC 2025 Highlights: China's Indigenous PCSK9 Inhibitor Contributes to Novel Lipid-Management Strategies
-
10:25-10:45从单抗发展史看中国企业的创新与突破Innovation and Breakthroughs of Chinese Enterprises: Perspectives from the Evolution of Monoclonal Antibodies
-
10:45-11:05PCI术后高效血脂管理策略Strategies for Efficient Lipid Management Post-Percutaneous Coronary Intervention
-
11:05-11:25FLAVOUR IV：使用PCSK9抑制剂进一步降脂对冠状动脉CT血管造影提示的高危斑块的心血管结局影响Further Lipid-Lowering with PCSK9 Inhibitors for Cardiovascular Outcomes in High-Risk Coronary Plaques Assessed by CT Angiography
-
10:00-10:05
-
11:55-12:00